Dr. Christopher Kepley
Dr. Christopher Kepley (Joint School of Nanoscience and Nanoengineering) received new funding from UNC-Chapel Hill School of Medicine/Prime: National Institutes of Health for the project “A Role for Glycolipids and Unconventional T Cell Subsets in Alpha-Gal Allergy.” The overall goal of this application is to determine if glycolipid and unconventional… Continue reading…